Recombinomics | Elegant Evolution






Home Founder What's New In The News Consulting





























H1N1 Consulting

Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents 



Audio:Jan24 Feb11 Feb21 Mar21 RSS Feed twitter News Now                         

Commentary

Three More Jiangsu H7N9 Confirmed Cases
Recombinomics Commentary 15:00
April 2, 2013

Patients Xu, female, 45 years old, Jiangning District, engaged in live poultry slaughter.
Patients with a mulberry, female, 48 years old, Suqian Shuyang engaged in sheet metal processing
Patients Shen, male, 83 years old, Suzhou Wujiang District
Patients Zhang, female, 32 years old, Changzhou, now lives in Wuxi city, unemployed

The above translation describes 4 lab confirmed H7N9 cases in Jiangsu Province (see map).  Only the case (45F) was described previously.  No poultry contact is cited for the other three cases.  All four cases had disease onset dates between March 19 and 21 and all were hospitalized between March 27 and March 30.

The four cases increase the number of lab confirmed case in China to 7.  Most or all of these cases were severe and at least two were fatal.  However, media reports describe a Shanghai cluster as well as multiple additional lab confirmed cases in Shanghai.

This explosion of H7N9 cases in Shanghai and adjacent provinces (Jiangsu and Anhui) are likely linked to a novel subclade which has a PB2 E627K, N9 with a 15 BP deletion, and a subset also have H7 Q226L (never reported in natural H5N1 bird flu).

Only the first three have been cited by WHO.

 
The large number of cases and the presence of key genetic markers associated with human adaptation raise serious pandemic concerns.

Media Link

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2013 Recombinomics.  All rights reserved.